 SAN DIEGO , June 21, 2022 PRNewswire -- Aethlon Medical, Inc. Nasdaq: AEMD, a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its fiscal year ended March 31, 2022, at 4:15 p.m. EST on Tuesday, June 28, 2022. 